<!DOCTYPE html>
<html lang="en">
<head>        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">    <link
        rel="stylesheet"
        href="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/css/bootstrap.min.css"
        integrity="sha384-Gn5384xqQ1aoWXA+058RXPxPg6fy4IWvTNh0E263XmFcJlSAwiGgFAW/dAiS6JXm"
        crossorigin="anonymous"
    />
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/c3/0.6.12/c3.min.css"/>
    <style>
        h2 {
            margin-top: 35px;
        }

        html, body {
            height: 100%;
        }

        body {
            display: flex;
            flex-flow: column;
        }

        .footer {
            margin-top: auto;
            padding-top: 1em;
            background-color: #f5f5f5;
        }
    </style>    <title>UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN</title></head>

<body>
<nav class="navbar navbar-expand-lg navbar-light bg-light">
    <span class="navbar-brand">
        Molecular Signatures Database
    </span>
</nav>

<div class="container" style="margin-top: 50px; margin-bottom: 50px">
<div class="card">
        <div class="card-header">
            UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
        </div>
        <div class="card-body">
                <p>Cysteinyl leukotrienes (cysLT), i.e., LTC4, LTD4, and LTE4, are lipid mediators derived from the 5-lipoxygenase pathway, and the cysLT receptors cysLT1-R/cysLT2-R mediate inflammatory tissue reactions. Although endothelial cells (ECs) predominantly express cysLT2-Rs, their role in vascular biology remains to be fully understood. To delineate cysLT2-R actions, we stimulated human umbilical vein EC with LTD4 and determined early induced genes. We also compared LTD4 effects with those induced by thrombin that binds to protease-activated receptor (PAR)-1. Stringent filters yielded 37 cysLT2-R- and 34 PAR-1-up-regulated genes (&gt;2.5-fold stimulation). Most LTD4-regulated genes were also induced by thrombin. Moreover, LTD4 plus thrombin augmented gene expression when compared with each agonist alone. Strongly induced genes were studied in detail: Early growth response (EGR) and nuclear receptor subfamily 4 group A transcription factors; E-selectin; CXC ligand 2; IL-8; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif 1 (ADAMTS1); Down syndrome critical region gene 1 (DSCR1); tissue factor (TF); and cyclooxygenase 2. Transcripts peaked at approximately 60 min, were unaffected by a cysLT1-R antagonist, and were superinduced by cycloheximide. The EC phenotype was markedly altered: LTD4 induced de novo synthesis of EGR1 protein and EGR1 localized in the nucleus; LTD4 up-regulated IL-8 formation and secretion; and LTD4 raised TF protein and TF-dependent EC procoagulant activity. These data show that cysLT2-R activation results in a proinflammatory EC phenotype. Because LTD4 and thrombin are likely to be formed concomitantly in vivo, cysLT2-R and PAR-1 may cooperate to augment vascular injury.</p>
            <dl>
                <dt>Local Unique Identifier</dt>
                <dd><a href="https://bioregistry.io/msigdb:M9162">M9162</a>
                </dd>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            in taxon (<code>RO:0002162</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/NCBITaxon:9606">NCBITaxon:9606</a></li>
                        </ol>
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            has part (<code>BFO:0000051</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/ncbigene:3164">ncbigene:3164</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8013">ncbigene:8013</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1390">ncbigene:1390</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3759">ncbigene:3759</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4739">ncbigene:4739</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:81575">ncbigene:81575</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:2920">ncbigene:2920</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1843">ncbigene:1843</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10397">ncbigene:10397</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1827">ncbigene:1827</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5166">ncbigene:5166</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3576">ncbigene:3576</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:7538">ncbigene:7538</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:22936">ncbigene:22936</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:84159">ncbigene:84159</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:150094">ncbigene:150094</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4170">ncbigene:4170</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5997">ncbigene:5997</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1960">ncbigene:1960</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1326">ncbigene:1326</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1839">ncbigene:1839</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10365">ncbigene:10365</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:2152">ncbigene:2152</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1958">ncbigene:1958</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3491">ncbigene:3491</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5743">ncbigene:5743</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:467">ncbigene:467</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:2355">ncbigene:2355</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:9314">ncbigene:9314</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:9510">ncbigene:9510</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4929">ncbigene:4929</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10370">ncbigene:10370</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6401">ncbigene:6401</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3142">ncbigene:3142</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:2669">ncbigene:2669</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:650">ncbigene:650</a></li>
                        </ol>
                    </dt>
            </dl>
            <span class="badge badge-warning">Term generation via PyOBO is currently under construction</span>
            <blockquote>
                Term(reference=Reference(prefix=&#39;msigdb&#39;, identifier=&#39;M9162&#39;, name=&#39;UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN&#39;), definition=&#39;Cysteinyl leukotrienes (cysLT), i.e., LTC4, LTD4, and LTE4, are lipid mediators derived from the 5-lipoxygenase pathway, and the cysLT receptors cysLT1-R/cysLT2-R mediate inflammatory tissue reactions. Although endothelial cells (ECs) predominantly express cysLT2-Rs, their role in vascular biology remains to be fully understood. To delineate cysLT2-R actions, we stimulated human umbilical vein EC with LTD4 and determined early induced genes. We also compared LTD4 effects with those induced by thrombin that binds to protease-activated receptor (PAR)-1. Stringent filters yielded 37 cysLT2-R- and 34 PAR-1-up-regulated genes (&gt;2.5-fold stimulation). Most LTD4-regulated genes were also induced by thrombin. Moreover, LTD4 plus thrombin augmented gene expression when compared with each agonist alone. Strongly induced genes were studied in detail: Early growth response (EGR) and nuclear receptor subfamily 4 group A transcription factors; E-selectin; CXC ligand 2; IL-8; a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif 1 (ADAMTS1); Down syndrome critical region gene 1 (DSCR1); tissue factor (TF); and cyclooxygenase 2. Transcripts peaked at approximately 60 min, were unaffected by a cysLT1-R antagonist, and were superinduced by cycloheximide. The EC phenotype was markedly altered: LTD4 induced de novo synthesis of EGR1 protein and EGR1 localized in the nucleus; LTD4 up-regulated IL-8 formation and secretion; and LTD4 raised TF protein and TF-dependent EC procoagulant activity. These data show that cysLT2-R activation results in a proinflammatory EC phenotype. Because LTD4 and thrombin are likely to be formed concomitantly in vivo, cysLT2-R and PAR-1 may cooperate to augment vascular injury.&#39;, provenance=[Reference(prefix=&#39;pubmed&#39;, identifier=&#39;16606835&#39;, name=None)], relationships=defaultdict(&lt;class &#39;list&#39;&gt;, {TypeDef(reference=Reference(prefix=&#39;RO&#39;, identifier=&#39;0002162&#39;, name=&#39;in taxon&#39;), comment=None, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=None, holds_over_chain=None): [Reference(prefix=&#39;NCBITaxon&#39;, identifier=&#39;9606&#39;, name=&#39;Homo sapiens&#39;)], TypeDef(reference=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000051&#39;, name=&#39;has part&#39;), comment=&#39;Inverse of part_of&#39;, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000050&#39;, name=&#39;part of&#39;), holds_over_chain=None): [Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3164&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8013&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1390&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3759&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4739&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;81575&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2920&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1843&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10397&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1827&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5166&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3576&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;7538&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;22936&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;84159&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;150094&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4170&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5997&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1960&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1326&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1839&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10365&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2152&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1958&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3491&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5743&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;467&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2355&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;9314&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;9510&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4929&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10370&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6401&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3142&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2669&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;650&#39;, name=None)]}), properties=defaultdict(&lt;class &#39;list&#39;&gt;, {&#39;category_code&#39;: [&#39;C2&#39;], &#39;sub_category_code&#39;: [&#39;CGP&#39;], &#39;contributor&#39;: [&#39;Arthur Liberzon&#39;], &#39;exact_source&#39;: [&#39;Table 1S&#39;]}), parents=[], synonyms=[], xrefs=[], alt_ids=[], namespace=None, is_obsolete=False)
            </blockquote>
        </div>
    </div></div>

<footer class="footer">
    <p class="small text-center text-muted">
        Generated with PyOBO
    </p>
</footer>

<script src="https://code.jquery.com/jquery-3.2.1.slim.min.js"
        integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN"
        crossorigin="anonymous"></script>
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/js/bootstrap.min.js"
        integrity="sha384-JZR6Spejh4U02d8jOt6vLEHfe/JQGiRRSQQxSfFWpi1MquVdAyjUar5+76PVCmYl"
        crossorigin="anonymous"></script></body>
</html>